Top

Strahlentherapie und Onkologie

Published in:

01-04-2012 | Original article

Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines

Authors: D. Schilling, C. Bayer, K. Emmerich, M. Molls, P. Vaupel, R.M. Huber, Prof. Dr. G. Multhoff

Published in: Strahlentherapie und Onkologie | Issue 4/2012

Abstract

Background and purpose

High levels of hypoxia inducible factor (HIF)-1α in tumors are reported to be associated with tumor progression and resistance to therapy. To examine the impact of HIF-1α on radioresistance under normoxia, the sensitivity towards irradiation was measured in human tumor cell lines that differ significantly in their basal HIF-1α levels.

Material and methods

HIF-1α levels were quantified in lysates of H1339, EPLC-272H, A549, SAS, XF354, FaDu, BHY, and CX- tumor cell lines by ELISA. Protein levels of HIF-1α, HIF-2α, carbonic anhydrase IX (CA IX), and GAPDH were assessed by Western blot analysis. Knock-down experiments were performed using HIF-1α siRNA. Clonogenic survival after irradiation was determined by the colony forming assay.

Results

According to their basal HIF-1α status, the tumor cell lines were divided into low (SAS, XF354, FaDu, A549, CX-), intermediate (EPLC-272H, BHY), and high (H1339) HIF-1α expressors. The functionality of the high basal HIF-1α expression in H1339 cells was proven by reduced CA IX expression after knocking-down HIF-1α. Linear regression analysis revealed no correlation between basal HIF-1α levels and the survival fraction at either 2 or 4 Gy in all tumor cell lines investigated.

Conclusion

Our data suggest that basal HIF-1α levels in human tumor cell lines do not predict their radiosensitivity under normoxia.

Aebersold DM, Burri P, Beer KT et al (2001) Expression of hypoxia-inducible factor-1a: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61:2911–2916PubMed

Akakura N, Kobayashi M, Horiuchi I et al (2001) Constitutive expression of hypoxia-inducible factor-1a renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 61:6548–6554PubMed

Appelhoff RJ, Tian YM, Raval RR et al (2004) Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279:38458–38465PubMedCrossRef

Aprelikova O, Pandolfi S, Tackett S et al (2009) Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response. Cancer Res 69:616–624PubMedCrossRef

Berra E, Benizri E, Ginouves A et al (2003) HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J 22:4082–4090PubMedCrossRef

Carmeliet P, Dor Y, Herbert JM et al (1998) Role of HIF-1a in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485–490PubMedCrossRef

Chan DA, Sutphin PD, Denko NC, Giaccia AJ (2002) Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 277:40112–40117PubMedCrossRef

Dang DT, Chen F, Gardner LB et al (2006) Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 66:1684–936PubMedCrossRef

Dellas K, Bache M, Pigorsch SU et al (2008) Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol 184:169–174PubMedCrossRef

10.

Dewhirst MW, Cao Y, Li CY, Moeller B (2007) Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy. Radiother Oncol 83:249–255PubMedCrossRef

11.

Fu XS, Choi E, Bubley GJ, Balk SP (2005) Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 63:215–221PubMedCrossRef

12.

Greijer AE, Wall E van der (2004) The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 57:1009–1014PubMedCrossRef

13.

Jung SY, Song HS, Park SY (2011) Pyruvate promotes tumor angiogenesis through HIF-1-dependent PAI-1 expression. Int J Oncol 38:571–576PubMed

14.

Kappler M, Taubert H, Holzhausen HJ et al (2008) Immunohistochemical detection of HIF-1a and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters. Strahlenther Onkol 184:393–399PubMedCrossRef

15.

Kessler J, Hahnel A, Wichmann H et al (2010) HIF-1a inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression. BMC Cancer 10:605PubMedCrossRef

16.

Kim WY, Oh SH, Woo JK et al (2009) Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1a. Cancer Res 69:1624–1632PubMedCrossRef

17.

Koukourakis MI, Giatromanolaki A, Sivridis E et al (2002) Hypoxia-inducible factor (HIF1 α and HIF2 α), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 53:1192–202PubMedCrossRef

18.

Krieg M, Haas R, Brauch H et al (2000) Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19:5435–5443PubMedCrossRef

19.

Liu J, Zhang J, Wang X et al (2010) HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells. Exp Cell Res 316:1985–1993PubMedCrossRef

20.

Maftei CA, Bayer C, Shi K et al (2011) Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-)fluorescence techniques. Strahlenther Onkol 187:260–266PubMedCrossRef

21.

Moeller BJ, Dreher MR, Rabbani ZN et al (2005) Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 8:99–110PubMedCrossRef

22.

Multhoff G, Botzler C, Jennen L et al (1997) Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol 158:4341–4350PubMed

23.

Nordsmark M, Eriksen JG, Gebski V et al (2007) Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients. Radiother Oncol 83:389–397PubMedCrossRef

24.

Paltoglou SM, Roberts BJ (2005) Role of the von Hippel-Lindau tumour suppressor protein in the regulation of HIF-1alpha and its oxygen-regulated transactivation domains at high cell density. Oncogene 24:3830–3835PubMedCrossRef

25.

Sasabe E, Tatemoto Y, Li D et al (2005) Mechanism of HIF-1a-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci 96:394–402PubMedCrossRef

26.

Schilling D, Gehrmann M, Steinem C et al (2009) Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells. FASEB J 23:2467–2477PubMedCrossRef

27.

Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721–732PubMedCrossRef

28.

Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29:625–634PubMedCrossRef

29.

Staab A, Fleischer M, Loeffler J et al (2011) Small interfering RNA targeting HIF-1a reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro. Strahlenther Onkol 187:252–259PubMedCrossRef

30.

Strofer M, Jelkmann W, Depping R (2011) Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF. Strahlenther Onkol 187:393–400PubMedCrossRef

31.

Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225–239PubMedCrossRef

32.

Vaupel P, Mayer A, Höckel M (2004) Tumor hypoxia and malignant progression. Methods Enzymol 381:335–354PubMedCrossRef

33.

Zips D, Boke S, Kroeber T et al (2011) Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control. Strahlenther Onkol 187:306–310PubMedCrossRef

Title: Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines
Authors: D. Schilling
C. Bayer
K. Emmerich
M. Molls
P. Vaupel
R.M. Huber
Prof. Dr. G. Multhoff
Publication date: 01-04-2012
Publisher: Springer-Verlag
Published in: Strahlentherapie und Onkologie / Issue 4/2012
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-011-0051-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines

Abstract

Background and purpose

Material and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background and purpose

Material and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2012

LINAC-radiosurgery for nonsecreting pituitary adenomas

Lebensqualität nach prophylaktischer Ganzhirnbestrahlung beim lokal fortgeschrittenen, nicht-kleinzelligen Bronchialkarzinom

Pitfalls in radiation oncology

Gemcitabin-basierte Strahlenchemotherapie beim lokal fortgeschrittenen Pankreaskarzinom – eine Metaanalyse

Stereotactic LINAC radiosurgery for the treatment of brainstem cavernomas

Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression